| http://www.w3.org/ns/prov#value | - It is solely whether the claims to isolated BRCA DNA, to methods for comparing DNA sequences, and to a process for screening potential cancer therapeutics meet the threshold test for patent-eligible subject matter under 35 U.S.C. ?? 101 in light of various Supreme Court holdings, particularly including Mayo.
|
